1. Myth: Only women with a family history of breast cancer are at risk.
Reality: ALL women are at risk for breast cancer. According to the American Cancer Society, roughly 70% of women diagnosed with breast cancer have no identifiable risk factors for the disease. But the family-history risks are these: If a first-degree relative (a parent, sibling, or child) has had or has breast cancer, your risk of developing the disease approximately doubles. Having two first-degree relatives with the disease increases your risk even more.
2. Myth: Wearing an underwire bra increases your risk of getting breast cancer.
Reality: Claims that underwire bras compress the lymphatic system of the breast, causing toxins to accumulate and cause breast cancer, have been widely debunked as unscientific. The consensus is that neither the type of bra you wear nor the tightness of your underwear or other clothing has any connection to breast cancer risk.
3. Myth: Wearing antiperspirant increases your risk of getting breast cancer.
Reality: The American Cancer Society discredits this rumor, but admits that more research is needed. One small study did stumble on traces of parabens in a tiny sample of breast cancer tumors. Parabens, used as preservatives in some antiperspirants, have weak estrogen-like properties, but the study in question made no cause-and-effect connection between parabens and breast cancer, nor did it conclusively identify the source of the parabens found in tumors.
Written by: admin
(This information was released on June 2 by the U.S. Food and Drug Administration. The original release can be found here.)
Telethermographic, ‘infrared’ devices not approved for primary cancer screening
The U.S. Food and Drug Administration h aswarned women not to substitute breast thermography for mammography to screen for breast cancer.
Unlike mammography, in which an X-ray of the breast is taken, thermography produces an infrared image that shows the patterns of heat and blood flow on or near the surface of the body. Some health care providers claim thermography is superior to mammography as a screening method for breast cancer because it does not require radiation exposure or breast compression.
However, the FDA is unaware of any valid scientific evidence showing that thermography, when used alone, is effective in screening for breast cancer. To date, the FDA has not approved a thermography device (also referred to as a telethermographic device) for use as a stand-alone to screen or diagnose breast cancer. The FDA has cleared thermography devices for use only as an additional diagnostic tool for breast cancer screening and diagnosis. Therefore, FDA says, thermography devices should not be used as a stand-alone method for breast cancer screening or diagnosis.
Written by: admin